In Star Health’s IPO, a moment of truth for Rakesh Jhunjhunwala

Star is set to become the first standalone health insurance company in India to go public. Will its valuation and a resurgent pandemic spoil the party?

29 November, 202115 min
0
Google Preferred Source Badge
Share
Getting your Trinity Audio player ready...
In Star Health’s IPO, a moment of truth for Rakesh Jhunjhunwala

Why read this story?

Editor's note: Star Health and Allied Insurance’s initial public offer of shares should have been among the highlights of this year’s unending public listing frenzy. After all, at Rs 7,249 crore, it is the third largest in terms of size this year, behind only those of Paytm and Zomato.  Yet, Star Health’s draft red herring prospectus, filed ahead of its public issue of shares, has escaped public scrutiny. Unlike the frenzy in the run-up to Paytm and Zomato’s IPOs, Star Health hasn’t attracted any newspaper headlines that deliver verdicts on its draft prospectus or lengthy Twitter threads by analysts dissecting every aspect of its business model. Nothing by way of recommendations for retail investors on YouTube or Instagram as well.  Puzzling, given this is a company with a track record of profitability in a sector that is destined to grow. For starters, this is the first standalone health insurer to go public in India. It comes amid fears of a resurgence of the pandemic. And, it precedes the mega-IPO of government-owned Life Insurance Corp. of India, speculated to come up early next …

You may also like

Business
Story image

IPO pipeline likely to stall despite SEBI flexibility

Promoters balk at smaller issues and uncertain pricing, choosing to wait out volatility.

Business
Story image

MFs hold up India’s IPO market, their investors foot the bill

As retail interest in public issuances fades, mutual funds are filling the gap—funding promoter exits and delivering subpar returns to the very investors they represent.

Internet
Story image

An indebted Captain Fresh seeks an IPO bailout

The seafood company solved its demand problem by aggressively buying global distributors. Now it has a financing problem that it can't solve without public money.